Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L; HERALD Study Group. Kremsner PG, et al. Among authors: lehmann c. Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826381 Free PMC article. Clinical Trial.
Results of the Cologne Corona Surveillance (CoCoS) study - a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection in adults.
Oberste M, Schnörch N, Shah-Hosseini K, Asenova T, Dewald F, Lehmann C, Buess M, Fätkenheuer G, Klein F, Rosenberger KD, Kossow A, Neuhann F, Hellmich M. Oberste M, et al. Among authors: lehmann c. BMC Public Health. 2023 Feb 6;23(1):260. doi: 10.1186/s12889-023-15047-6. BMC Public Health. 2023. PMID: 36747171 Free PMC article.
Considerations for Alternative Decision-Making When Transitioning to Adulthood for Youth With Intellectual and Developmental Disabilities: Policy Statement.
Turchi RM, Kuo DZ, Rusher JW, Seltzer RR, Lehmann CU, Grout RW; COUNCIL ON CHILDREN WITH DISABILITIES; COMMITTEE ON MEDICAL LIABILITY AND RISK MANAGEMENT. Turchi RM, et al. Among authors: lehmann cu. Pediatrics. 2024 May 28:e2024066841. doi: 10.1542/peds.2024-066841. Online ahead of print. Pediatrics. 2024. PMID: 38804066
[Outpatient parenteral anti-infective therapy (OPAT)].
Gehlen L, Lehmann C. Gehlen L, et al. Among authors: lehmann c. Inn Med (Heidelb). 2024 May 14. doi: 10.1007/s00108-024-01707-1. Online ahead of print. Inn Med (Heidelb). 2024. PMID: 38743073 German.
Safe and Equitable Pediatric Clinical Use of AI.
Handley JL, Lehmann CU, Ratwani RM. Handley JL, et al. Among authors: lehmann cu. JAMA Pediatr. 2024 May 13. doi: 10.1001/jamapediatrics.2024.0897. Online ahead of print. JAMA Pediatr. 2024. PMID: 38739385
Real-Time Electronic Patient Portal Use Among Emergency Department Patients.
Turer RW, McDonald SA, Lehmann CU, Thakur B, Dutta S, Taylor RA, Rose CC, Frisch A, Feterik K, Norquist C, Baker CK, Nielson JA, Cha D, Kwan B, Dameff C, Killeen JP, Hall MK, Doerning RC, Rosenbloom ST, Distaso C, Steitz BD. Turer RW, et al. Among authors: lehmann cu. JAMA Netw Open. 2024 May 1;7(5):e249831. doi: 10.1001/jamanetworkopen.2024.9831. JAMA Netw Open. 2024. PMID: 38700859 Free PMC article.
1,261 results